MY142110A - Matrix for sustained, invariant and independent release of active compounds - Google Patents

Matrix for sustained, invariant and independent release of active compounds

Info

Publication number
MY142110A
MY142110A MYPI20043893A MY142110A MY 142110 A MY142110 A MY 142110A MY PI20043893 A MYPI20043893 A MY PI20043893A MY 142110 A MY142110 A MY 142110A
Authority
MY
Malaysia
Prior art keywords
matrix
invariant
sustained
active compounds
independent release
Prior art date
Application number
Inventor
Bianca Bruegmann
Silke Moehlau
Christof Spitzley
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Priority to MYPI20043893 priority Critical patent/MY142110A/en
Publication of MY142110A publication Critical patent/MY142110A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

THE INVENTION CONCERNS A STORAGE STABLE PHARMACEUTICAL FORMULATION COMPRISING PREFERABLY TWO ACTIVE COMPOUNDS IN A NON-SWELLABLE DIFFUSION MATRIX, WHEREBY THE COMPOUNDS ARE RELEASED FROM THE MATRIX IN A SUSTAINED, INVARIANT AND, IF SEVERAL COMPOUNDS ARE PRESENT, INDEPENDENT MANNER AND THE MATRIX IS DETERMINED WITH RESPECT TO ITS SUBSTANTIAL RELEASE CHARACTERISTICS BY ETHYCELLULOSE AND AT LEAST ONE FATTY ALCOHOL. THE INVENTION ALSO CONCERNS METHODS FOR PRODUCING SUCH PHARMACEUTICAL FORMULATIONS.
MYPI20043893 2004-09-23 2004-09-23 Matrix for sustained, invariant and independent release of active compounds MY142110A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20043893 MY142110A (en) 2004-09-23 2004-09-23 Matrix for sustained, invariant and independent release of active compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20043893 MY142110A (en) 2004-09-23 2004-09-23 Matrix for sustained, invariant and independent release of active compounds

Publications (1)

Publication Number Publication Date
MY142110A true MY142110A (en) 2010-09-15

Family

ID=47320705

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20043893 MY142110A (en) 2004-09-23 2004-09-23 Matrix for sustained, invariant and independent release of active compounds

Country Status (1)

Country Link
MY (1) MY142110A (en)

Similar Documents

Publication Publication Date Title
TW200716113A (en) Matrix for sustained, invariant and independent release of active compounds
IL155964A0 (en) A pharmaceutical composition comprising an active ingredient uniformly dispersed in a matrix
UA74339C2 (en) Dosage form of proton pump inhibitor representing individual matrix-included units and method for its manufacture
CR10032A (en) SOLID PREPARATION
AR099437A2 (en) MATRIX FOR SUSTAINED, INVARIABLE AND INDEPENDENT RELEASE OF ACTIVE COMPOUNDS
WO2007128923A3 (en) Method for the preparation of a biocompatible gel with controlled release of one or more active ingredients with low solubility in water, gels thus obtained and their use
WO2006035417A3 (en) Dihydropyrimidine microcapsule - formulations
PA8575701A1 (en) ACID INSULIN PREPARATIONS WITH IMPROVED STABILITY
ECSP088560A (en) FORMULATION OF SUSTAINED RELEASE THAT INCLUDES OCTREOTIDE AND TWO OR MORE POLYMACTIDE-CO-GLYCOLIDE POLYMERS
WO2008118133A3 (en) Silk microspheres for encapsulation and controlled release
SI1341528T1 (en) Rapidly disintegrating tablet comprising an acid-labile active ingredient
WO2008052033A3 (en) Ibuprofen composition
PE20070192A1 (en) HIGHLY BIO-AVAILABLE ORAL DELAYED-RELEASE DOSAGE FORMS OF O-DEMETHYLVENLAFAXINE SUCCINATE
MY143793A (en) Non-tabletted, chewable, individually dosed administration forms
TWI255720B (en) Novel preparation and administration form comprising an acid-labile active compound and process for production thereof
WO2007025182A3 (en) Drug compositions containing controlled release hypromellose matrices
SE0302924D0 (en) Pharmaceutical composition having a cationic excipient
NO20055601L (en) Pharmaceutical preparation in the form of a hydrogel for transdermal administration of active ingredients
WO2005115346A3 (en) Pharmaceutical composition containing risperidone
ATE439125T1 (en) FENOFIBRATE TRAY AND METHOD FOR PRODUCING
AR040764A1 (en) PHARMACEUTICAL FORMULATIONS OF EPINASTINE, PSEUDOEFEDRINE AND METHYLFEDRINE
WO2004073592A3 (en) Semi-solid immediate-release oral formulations comprising an anticancer hydrophobic agent, a polyglycolised glyceride and a hydrophilic carrier
AR028699A1 (en) NEW FORMULATION
GB0322994D0 (en) Organic compounds
苏曼 Jack’s Schedule